Avicenna.AI has launched CINA-iPE, a CE-Marked artificial intelligence (AI) program for analyzing chest CT scans for the presence of incidental pulmonary embolism.
The company said it will demonstrate CINA-iPE for the first time at ECR 2023 in Vienna. CINA-iPE is the first tool in CINA Incidental, the company's suite of medical imaging programs for detecting unsuspected pathologies on CT scans.
CINA Incidental sits alongside the company's existing suite, CINA ER, which includes a range of U.S. Food and Drug Administration-cleared and CE-Marked tools for neurovascular and thoraco-abdominal emergencies, the company said.
